Skip to main content
ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
22.67
+0.37 (1.66%)
Apr 28, 2026, 4:00 PM EDT - Market closed

ACADIA Pharmaceuticals Revenue

In the year 2025, ACADIA Pharmaceuticals had annual revenue of $1.07B with 11.87% growth. ACADIA Pharmaceuticals had revenue of $283.99M in the quarter ending December 31, 2025, with 9.39% growth.

Revenue (ttm)
$1.07B
Revenue Growth
+11.87%
P/S Ratio
3.61
Revenue / Employee
$1,342,738
Employees
798
Market Cap
3.87B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.07B113.71M11.87%
Dec 31, 2024957.80M231.36M31.85%
Dec 31, 2023726.44M209.20M40.45%
Dec 31, 2022517.24M33.09M6.83%
Dec 31, 2021484.15M42.39M9.60%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Legend Biotech 1.03B
Telix Pharmaceuticals 803.79M
Catalyst Pharmaceuticals 588.99M
Travere Therapeutics 490.73M
Tango Therapeutics 62.38M
NewAmsterdam Pharma Company 22.50M
Crinetics Pharmaceuticals 7.70M
Revenue Rankings

ACAD News

More News